189 related articles for article (PubMed ID: 23264042)
1. Reevaluation of the safety of induced pluripotent stem cells: a call from somatic mosaicism.
Liu W; Li M; Qu J; Yi F; Liu GH
Protein Cell; 2013 Feb; 4(2):83-5. PubMed ID: 23264042
[TBL] [Abstract][Full Text] [Related]
2. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
3. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
Abyzov A; Mariani J; Palejev D; Zhang Y; Haney MS; Tomasini L; Ferrandino AF; Rosenberg Belmaker LA; Szekely A; Wilson M; Kocabas A; Calixto NE; Grigorenko EL; Huttner A; Chawarska K; Weissman S; Urban AE; Gerstein M; Vaccarino FM
Nature; 2012 Dec; 492(7429):438-42. PubMed ID: 23160490
[TBL] [Abstract][Full Text] [Related]
4. Copy number variation and selection during reprogramming to pluripotency.
Hussein SM; Batada NN; Vuoristo S; Ching RW; Autio R; Närvä E; Ng S; Sourour M; Hämäläinen R; Olsson C; Lundin K; Mikkola M; Trokovic R; Peitz M; Brüstle O; Bazett-Jones DP; Alitalo K; Lahesmaa R; Nagy A; Otonkoski T
Nature; 2011 Mar; 471(7336):58-62. PubMed ID: 21368824
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
[TBL] [Abstract][Full Text] [Related]
6. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.
Casamassa A; Ferrari D; Gelati M; Carella M; Vescovi AL; Rosati J
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182809
[TBL] [Abstract][Full Text] [Related]
7. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
8. Influence of ATM-Mediated DNA Damage Response on Genomic Variation in Human Induced Pluripotent Stem Cells.
Lu J; Li H; Baccei A; Sasaki T; Gilbert DM; Lerou PH
Stem Cells Dev; 2016 May; 25(9):740-7. PubMed ID: 26935587
[TBL] [Abstract][Full Text] [Related]
9. Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies.
Brouwer M; Zhou H; Nadif Kasri N
Stem Cell Rev Rep; 2016 Feb; 12(1):54-72. PubMed ID: 26424535
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity.
Chen Y; Guo L; Chen J; Zhao X; Zhou W; Zhang C; Wang J; Jin L; Pei D; Zhang F
BMC Genomics; 2014 Jan; 15():79. PubMed ID: 24472662
[TBL] [Abstract][Full Text] [Related]
11. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.
Ray A; Joshi JM; Sundaravadivelu PK; Raina K; Lenka N; Kaveeshwar V; Thummer RP
Stem Cell Rev Rep; 2021 Dec; 17(6):1954-1974. PubMed ID: 34100193
[TBL] [Abstract][Full Text] [Related]
12. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
15. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
[TBL] [Abstract][Full Text] [Related]
16. X chromosome inactivation and epigenetic responses to cellular reprogramming.
Lessing D; Anguera MC; Lee JT
Annu Rev Genomics Hum Genet; 2013; 14():85-110. PubMed ID: 23662665
[TBL] [Abstract][Full Text] [Related]
17. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.
Rohani L; Johnson AA; Naghsh P; Rancourt DE; Ulrich H; Holland H
Stem Cells Transl Med; 2018 Dec; 7(12):867-875. PubMed ID: 30218497
[TBL] [Abstract][Full Text] [Related]
19. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
Yoshihara M; Oguchi A; Murakawa Y
Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
[TBL] [Abstract][Full Text] [Related]
20. Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism.
Nagata N; Yamanaka S
Circ Res; 2014 Jan; 114(3):505-10. PubMed ID: 24481841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
